I slayed the sleeping dragon A chance for complete and lasting remission from cancer
YESCARTA® CAR T-cell therapy is a single infusion approved for follicular lymphoma, a type of non-Hodgkin lymphoma. It may be an option when at least two other kinds of treatment have failed to control your cancer. YESCARTA directs your own immune system to recognize and destroy cancer cells, making complete and lasting remission possible.
YESCARTA was studied in 81 adults with follicular lymphoma who had experienced two or more treatment failures:
- 91% (74 out of 81) saw a decrease in cancer
- 60% (49 out of 81) achieved complete remission
- Most of the patients who achieved remission are still in remission a year and a half after treatment. Patients were followed for a median of about 18 months to gather these results
How to get started when you’re considering YESCARTA
Download the YESCARTA brochure
The brochure includes information about YESCARTA and how the treatment process works. Review with your oncologist to discuss if YESCARTA is an option for you.
Find an oncologist with YESCARTA experience
YESCARTA is available at Authorized Treatment Centers where medical staff is thoroughly trained and equipped to provide this type of therapy. Oncologists at Authorized Treatment Centers have the most experience with CAR T-cell therapy.
YESCARTA is a single infusion that puts millions of cancer‑fighting CAR T cells into your body
YESCARTA is different than other cancer medicines because it is made from your own white blood cells, which have been modified to recognize and destroy cancer cells.
Help is available
The Kite Konnect® Support Team is committed to assisting you throughout the treatment journey. For help finding an Authorized Treatment Center, or for information about the support resources that may be available to you once your physician has decided that CAR T-cell therapy is appropriate for you, call Kite Konnect at 1‑844‑454‑KITE , Monday–Friday, 5 am–6 pm PT.